Clinical Trial Update: A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial evaluating pemetrexed plus cisplatin in patients with refractory soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Yonsei University | Conditions: Sarcoma | Phase 2 | Status: COMPLETED